Objective The combination of stereotactic body radiation therapy(SBRT)and immune checkpoint inhibitors(ICIs)is actively being explored in advanced non-small-cell lung cancer(NSCLC)patients.However,little is known abou...Objective The combination of stereotactic body radiation therapy(SBRT)and immune checkpoint inhibitors(ICIs)is actively being explored in advanced non-small-cell lung cancer(NSCLC)patients.However,little is known about the optimal fractionation and radiotherapy target lesions in this scenario.This study investigated the effect of SBRT on diverse organ lesions and radiotherapy dose fractionation regimens on the prognosis of advanced NSCLC patients receiving ICIs.Methods The medical records of advanced NSCLC patients consecutively treated with ICIs and SBRT were retrospectively reviewed at our institution from Dec.2015 to Sep.2021.Patients were grouped according to radiation sites.Progression-free survival(PFS)and overall survival(OS)were recorded using the Kaplan-Meier method and compared between different treatment groups using the log-rank(Mantel-Cox)test.Results A total of 124 advanced NSCLC patients receiving ICIs combined with SBRT were identified in this study.Radiation sites included lung lesions(lung group,n=43),bone metastases(bone group,n=24),and brain metastases(brain group,n=57).Compared with the brain group,the mean PFS(mPFS)in the lung group was significantly prolonged by 13.3 months(8.5 months vs.21.8 months,HR=0.51,95%CI:0.28–0.92,P=0.0195),and that in the bone group prolonged by 9.5 months with a 43%reduction in the risk of disease progression(8.5 months vs.18.0 months,HR=0.57,95%CI:0.29–1.13,P=0.1095).The mPFS in the lung group was prolonged by 3.8 months as compared with that in the bone group.The mean OS(mOS)in the lung and bone groups was longer than that of the brain group,and the risk of death decreased by up to 60%in the lung and bone groups as compared with that of the brain group.When SBRT was concurrently given with ICIs,the mPFS in the lung and brain groups were significantly longer than that of the bone group(29.6 months vs.16.5 months vs.12.1 months).When SBRT with 8–12 Gy per fraction was combined with ICIs,the mPFS in the lung group was significantly prolonged as compared with展开更多
通过三生烟草(Sam Sun N.N)枯斑试验和接种TMV病毒的K326品种烟株体内生理指标分析,研究了氨基寡糖素与中微肥混配对烟草花叶病毒(TMV)的体外钝化、侵染抑制效果和综合防病效果,以及由其引起的烟叶叶绿素、防御酶活性及病程相关蛋白等...通过三生烟草(Sam Sun N.N)枯斑试验和接种TMV病毒的K326品种烟株体内生理指标分析,研究了氨基寡糖素与中微肥混配对烟草花叶病毒(TMV)的体外钝化、侵染抑制效果和综合防病效果,以及由其引起的烟叶叶绿素、防御酶活性及病程相关蛋白等生理指标变化。结果表明:三生烟草枯斑试验中,氨镁锌混配剂对TMV病毒有明显的体外钝化和侵染治疗效果,病毒抑制率分别比单独施用氨基寡糖素提高20.6和10.1个百分点;K326品种烟株接种TMV病毒施用相应药剂,接种后7、11和30 d时的病情指数均以氨镁锌混配剂处理<氨基寡糖素单剂<CK;而上述烟株体内叶绿素的含量和SOD、POD和PAL酶活性则以氨镁锌混配剂处理总体最高;氨镁锌混配剂处理诱导病程相关蛋白PR3和PR5相对表达量显著性升高,达到对照的0.79倍和1.51倍。这说明,氨基寡糖素与镁锌混配对抑制TMV侵染和提高烟株抗性的效果比单独施用氨基寡糖素好。展开更多
文摘Objective The combination of stereotactic body radiation therapy(SBRT)and immune checkpoint inhibitors(ICIs)is actively being explored in advanced non-small-cell lung cancer(NSCLC)patients.However,little is known about the optimal fractionation and radiotherapy target lesions in this scenario.This study investigated the effect of SBRT on diverse organ lesions and radiotherapy dose fractionation regimens on the prognosis of advanced NSCLC patients receiving ICIs.Methods The medical records of advanced NSCLC patients consecutively treated with ICIs and SBRT were retrospectively reviewed at our institution from Dec.2015 to Sep.2021.Patients were grouped according to radiation sites.Progression-free survival(PFS)and overall survival(OS)were recorded using the Kaplan-Meier method and compared between different treatment groups using the log-rank(Mantel-Cox)test.Results A total of 124 advanced NSCLC patients receiving ICIs combined with SBRT were identified in this study.Radiation sites included lung lesions(lung group,n=43),bone metastases(bone group,n=24),and brain metastases(brain group,n=57).Compared with the brain group,the mean PFS(mPFS)in the lung group was significantly prolonged by 13.3 months(8.5 months vs.21.8 months,HR=0.51,95%CI:0.28–0.92,P=0.0195),and that in the bone group prolonged by 9.5 months with a 43%reduction in the risk of disease progression(8.5 months vs.18.0 months,HR=0.57,95%CI:0.29–1.13,P=0.1095).The mPFS in the lung group was prolonged by 3.8 months as compared with that in the bone group.The mean OS(mOS)in the lung and bone groups was longer than that of the brain group,and the risk of death decreased by up to 60%in the lung and bone groups as compared with that of the brain group.When SBRT was concurrently given with ICIs,the mPFS in the lung and brain groups were significantly longer than that of the bone group(29.6 months vs.16.5 months vs.12.1 months).When SBRT with 8–12 Gy per fraction was combined with ICIs,the mPFS in the lung group was significantly prolonged as compared with
文摘通过三生烟草(Sam Sun N.N)枯斑试验和接种TMV病毒的K326品种烟株体内生理指标分析,研究了氨基寡糖素与中微肥混配对烟草花叶病毒(TMV)的体外钝化、侵染抑制效果和综合防病效果,以及由其引起的烟叶叶绿素、防御酶活性及病程相关蛋白等生理指标变化。结果表明:三生烟草枯斑试验中,氨镁锌混配剂对TMV病毒有明显的体外钝化和侵染治疗效果,病毒抑制率分别比单独施用氨基寡糖素提高20.6和10.1个百分点;K326品种烟株接种TMV病毒施用相应药剂,接种后7、11和30 d时的病情指数均以氨镁锌混配剂处理<氨基寡糖素单剂<CK;而上述烟株体内叶绿素的含量和SOD、POD和PAL酶活性则以氨镁锌混配剂处理总体最高;氨镁锌混配剂处理诱导病程相关蛋白PR3和PR5相对表达量显著性升高,达到对照的0.79倍和1.51倍。这说明,氨基寡糖素与镁锌混配对抑制TMV侵染和提高烟株抗性的效果比单独施用氨基寡糖素好。
